Peginterferon α-2b
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Peginterferon α-2b, covering 2024-12-24 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors [NA]